---

OSPE-1: Rickets (7 marks)

Q1. Probable diagnosis? (1 mark)

Q2. Which vitamin deficiency? (1 mark)

Q3. Different types of deficiency manifestations (2 marks)

• Skeletal: frontal bossing, pigeon chest, bowing of legs, knock knees, Harrison's sulcus (transverse depression from costal cartilage to axilla), rachitic rosary (swelling at costochondral junctions), delayed dentition, craniotabes
• Biochemical: low serum Ca, very low serum phosphate, markedly elevated ALP, elevated PTH

• Softening of bones, bone pain, muscle weakness, deformities of spine and pelvis, looser's zones (pseudo-fractures) on X-ray

• Due to low calcium: carpopedal spasm, Trousseau's sign, Chvostek's sign, laryngeal stridor

Q4. Different causes of this deficiency (2 marks)

1. Inadequate dietary intake - lack of fortified foods
2. Inadequate sunlight exposure - sun is needed for conversion of 7-dehydrocholesterol to Vitamin D3 in skin
3. Malabsorption - fat-soluble vitamin, so fat malabsorption (steatorrhoea, celiac disease) reduces absorption
4. Liver disease - impaired 25-hydroxylation (first activation step in liver)
5. Renal disease/chronic renal failure - impaired 1-alpha hydroxylation (second activation step in kidney) causing renal osteodystrophy
6. Exclusive breastfeeding without sunlight - breast milk is low in Vit D
7. Genetic causes - Vit D-dependent rickets type I (1-alpha hydroxylase deficiency), Type II (receptor defect)
8. Drugs - anticonvulsants (phenytoin) accelerate Vit D catabolism

Q5. Two biochemical roles of Vitamin D (1 mark)

1. Calcium and phosphate homeostasis: Active form 1,25-(OH)2 D3 (calcitriol) acts on intestine to increase absorption of calcium and phosphate by inducing synthesis of calcium-binding protein (calbindin)
2. Bone mineralization: Calcitriol acts on bone to stimulate osteoblasts for bone matrix mineralization and maintains the Ca × P product needed for hydroxyapatite deposition

---

OSPE-2: Albinism (8 marks)

Q1. Probable diagnosis? (1 mark)

Q2. Genetic defect? (1 mark)

Q3. Pattern of inheritance? (1 mark)

Q4. Different types of OCA? (1 mark)

1. OCA Type 1 (Tyrosinase-negative): Complete absence of tyrosinase activity, no pigment at all (as in this case)
2. OCA Type 2 (Tyrosinase-positive): P-gene mutation; some residual pigment, hair may be yellow/light
3. OCA Type 3 (Rufous albinism): TYRP1 gene mutation; reddish-brown pigmentation
4. OCA Type 4: SLC45A2 gene mutation; similar to Type 2

Q5. Other products synthesized from Tyrosine (2 marks)

1. Melanin - skin, hair, eye pigment (via DOPA → dopaquinone → melanin)
2. Catecholamines - DOPA → Dopamine → Norepinephrine → Epinephrine
3. Thyroid hormones - T3 (triiodothyronine) and T4 (thyroxine)
4. Fumarate and Acetoacetate - in catabolism (tyrosine is glucogenic and ketogenic)

Q6. Management protocol? (1 mark)

• Sun protection: High SPF sunscreen, protective clothing, sunglasses with UV protection
• Regular ophthalmologic follow-up for visual correction and monitoring of nystagmus
• Tinted lenses/corrective glasses for photophobia
• Regular dermatology review for early detection of skin cancers (melanoma, squamous cell carcinoma)
• No specific medical cure; management is supportive/preventive

Q7. Methods for prenatal diagnosis? (1 mark)

1. Molecular/DNA analysis - PCR and sequencing of TYR gene from chorionic villus sampling (CVS) or amniocentesis cells
2. Tyrosinase activity assay on fetal cells obtained by amniocentesis
3. Electron microscopy of fetal skin biopsy (reduced/absent melanosomes)

---

OSPE-1: Beriberi / Thiamine Deficiency (10 marks)

Q1. Probable diagnosis? (2 marks)

• Evidence: polished rice diet (thiamine removed in polishing), high-output cardiac failure (tachycardia, murmur, engorged neck veins, hepatomegaly, pulmonary congestion)

Q2. Nutrient deficiency? (2 marks)

Q3. Types of deficiency manifestations (2 marks)

1. Dry Beriberi (Neurological): Peripheral neuropathy - symmetric sensory and motor neuropathy starting in feet and legs, weakness, wasting of muscles, foot/wrist drop, burning feet
2. Wet Beriberi (Cardiovascular): High-output cardiac failure with dilated cardiomyopathy, tachycardia, peripheral vasodilation, oedema, cardiomegaly, crepitations, raised JVP - as seen in this case
3. Shoshin Beriberi: Acute, severe, potentially fatal cardiac failure; high-output failure with circulatory collapse
4. Wernicke-Korsakoff Syndrome (Cerebral): Primarily in alcoholics. Wernicke's: confusion, ataxia, ophthalmoplegia (triad). Korsakoff's: anterograde amnesia, confabulation (irreversible)
5. Infantile Beriberi: Occurs in breastfed infants of thiamine-deficient mothers; cardiac form common

Q4. Two biochemical roles of Thiamine (2 marks)

1. Pyruvate Dehydrogenase Complex (PDC): Converts pyruvate to Acetyl-CoA (links glycolysis to TCA cycle). Deficiency causes pyruvate accumulation and lactic acidosis, and failure of ATP production - explains cardiac dysfunction.
2. Alpha-Ketoglutarate Dehydrogenase: In TCA cycle, converts alpha-ketoglutarate to Succinyl-CoA. Also: Transketolase in HMP (Pentose Phosphate) pathway. Deficiency impairs nerve cell energy (nerves depend heavily on glucose oxidation).

Q5. Two rich dietary sources of Thiamine (2 marks)

1. Unpolished/whole grain cereals (rice bran, wheat germ), legumes (pulses, peas)
2. Yeast, pork, liver, nuts, sunflower seeds

• Note: Polished rice is a poor source - polishing removes the bran layer where thiamine is concentrated.

---

OSPE-2: Hypothyroidism (7 marks)

Q1. Probable diagnosis? (2 marks)

• High TSH + low fT4 = primary hypothyroidism (thyroid gland failure, pituitary compensates with high TSH)
• Clinical features: classic myxoedema picture - dry coarse skin, puffy face, slow reflexes, cold intolerance, weight gain

Q2. Why does the patient have anaemia? (1 mark)

• Normocytic normochromic anaemia due to decreased erythropoietin production secondary to reduced metabolic demand and oxygen consumption in hypothyroid state
• Thyroid hormones normally stimulate erythropoiesis; their deficiency leads to decreased RBC production
• Additionally, hypothyroidism leads to reduced absorption of iron (due to achlorhydria) and coexisting pernicious anaemia (autoimmune association) may cause megaloblastic anaemia
• Menorrhagia in hypothyroid women can also cause iron-deficiency anaemia

Q3. Two common causes of hypothyroidism (2 marks)

1. Autoimmune (Hashimoto's Thyroiditis): Most common cause in iodine-sufficient areas. Autoantibodies against TPO (thyroid peroxidase) and thyroglobulin; lymphocytic infiltration destroys thyroid tissue
2. Iodine deficiency: Most common cause worldwide; inadequate iodine for thyroid hormone synthesis
3. Others: Post-thyroidectomy, post-radioiodine therapy, drugs (amiodarone, lithium, antithyroid drugs)

Q4. Treatment plan? (1 mark)

• Starting dose: 25-50 mcg/day (lower in elderly/cardiac patients), titrate up
• Target: TSH within normal range (0.5-4.5 mIU/L)
• Monitor TSH every 6-8 weeks initially, then annually
• Treatment is lifelong

Q5. Congenital condition of hypothyroidism? (1 mark)

• Features: intellectual disability, short stature, thick tongue, umbilical hernia, pot-belly, coarse skin, myxoedematous facies, goitre (endemic cretinism from iodine deficiency)
• Neonatal screening (T4/TSH) is done to detect and treat early, preventing irreversible neurological damage

---

OSPE: Vitamin A Deficiency (8 marks)

Q1. Probable diagnosis? (2 marks)

Q2. Two ocular manifestations of Vitamin A deficiency (2 marks)

1. Night Blindness (Nyctalopia): Earliest symptom. Vitamin A (retinol) is required for synthesis of rhodopsin (visual purple) in rod cells. Deficiency impairs dark adaptation.
2. Bitot's Spots: Triangular, grayish-white, foamy/cheesy keratinized plaques on the conjunctiva (nasal and temporal to cornea) - characteristic sign
3. Conjunctival Xerosis: Dryness and keratinization of conjunctiva (loss of goblet cells)
4. Corneal Xerosis → Keratomalacia: Progressive dryness and softening/liquefaction of cornea → perforation → blindness (irreversible)

Q3. Different forms of Vitamin A and one differentiating feature (2 marks)

1. Retinol (Vitamin A1, all-trans-retinol): Active alcohol form stored in liver; found in animal foods (liver, dairy, eggs, fish); most biologically active
2. Retinal (Retinaldehyde): Aldehyde form; essential for vision (combines with opsin to form rhodopsin/iodopsin)
3. Retinoic Acid: Acid form; acts as a hormone-like molecule binding nuclear receptors (RAR/RXR); regulates gene expression, cell differentiation, growth - but CANNOT be converted back to retinol or retinal, so cannot support vision or reproduction
4. Beta-Carotene (Pro-vitamin A): Found in plant foods (orange/yellow/dark green vegetables); converted to retinol in intestinal mucosa by beta-carotene dioxygenase; one molecule gives 2 retinal molecules
5. Dehydroretinol (Vitamin A2): Found in freshwater fish

Q4. Rich dietary sources (2 marks)

• Preformed Vitamin A (Retinol): Liver (best source), cod liver oil, butter, full-fat dairy, egg yolk, oily fish
• Provitamin A (Beta-carotene): Carrots, sweet potato, pumpkin, mango, papaya, dark leafy greens (spinach, amaranth), red palm oil

Q5. Two biochemical roles of Vitamin A (2 marks)

1. Vision: 11-cis retinal combines with opsin (protein) to form rhodopsin in rod cells. On light exposure, rhodopsin is bleached → isomerization to all-trans retinal → nerve impulse for vision. Deficiency → night blindness.
2. Cell differentiation and growth: Retinoic acid binds nuclear receptors (RAR) and regulates transcription of genes involved in cell growth, differentiation, and development of epithelial tissues. Deficiency leads to squamous metaplasia and keratinization of epithelial cells (skin, cornea, mucous membranes).
3. Also: Antioxidant (beta-carotene), immune function, reproduction (retinol and retinal needed)

---

OSPE: Iron Deficiency Anaemia (8 marks)

Note: Peripheral smear shows hypochromic (consistent with IDA), though described as "normocytic" in question - early IDA may show normocytic picture before progressing to microcytic.

Q1. Probable diagnosis? (1 mark)

Q2. Deficient nutrient? (1 mark)

Q3. Function of Transferrin? (2 marks)

• Transferrin is a beta-1 glycoprotein synthesized in the liver
• It is the iron transport protein in plasma; each molecule can bind 2 Fe3+ ions
• It carries iron from sites of absorption (intestine) and storage (liver/spleen) to bone marrow and other tissues requiring iron
• Cells express transferrin receptors (TfR) - transferrin-iron complex binds TfR and is internalized via endocytosis; iron is released intracellularly
• In IDA: serum transferrin is high (liver produces more to capture every available iron), but transferrin saturation is low (not enough iron to bind)
• TIBC (Total Iron Binding Capacity) = indirect measure of transferrin; elevated in IDA

Q4. Different causes of IDA (1 mark)

1. Inadequate intake: Poor diet (especially vegetarians, infants, toddlers, junk food diet as in this case)
2. Increased demand: Pregnancy, lactation, rapid growth (infants, adolescents)
3. Chronic blood loss: Menorrhagia (most common in women), GI bleeding (peptic ulcer, hookworm, haemorrhoids, colorectal carcinoma)
4. Malabsorption: Coeliac disease, gastrectomy (loss of acid needed for Fe3+→Fe2+ conversion), inflammatory bowel disease
5. Defective transport: Atransferrinaemia (rare)

Q5. Management protocol? (1 mark)

• Oral iron therapy: Ferrous sulphate 200 mg TDS (or equivalent ferrous salt) for 3-6 months - to replenish stores after Hb normalizes
• Give with ascorbic acid (Vitamin C) to enhance absorption; avoid tea, milk, antacids
• Treat underlying cause (stop bleeding, treat malabsorption)
• Dietary advice: Increase iron-rich foods (red meat, green leafy vegetables, legumes)
• Parenteral iron if oral not tolerated or malabsorption
• Blood transfusion only if severe/symptomatic anaemia

Q6. Best sensitive test for diagnosis and why? (2 marks)

• Ferritin is the iron storage protein (in liver, spleen, bone marrow, macrophages)
• Serum ferritin directly reflects body iron stores
• Serum ferritin is the first to fall in iron deficiency (falls before Hb, serum iron, or MCV change) - making it the earliest and most sensitive marker
• Low serum ferritin (<12 mcg/L) = depleted iron stores = diagnostic of IDA
• However: Ferritin is an acute-phase reactant - may be falsely normal/high in inflammation/infection/liver disease even with IDA (limitation)
• Other tests: Serum iron (low), TIBC (high), Transferrin saturation (low <16%), RDW (high in IDA), peripheral smear (hypochromic microcytic), bone marrow iron stores (gold standard but invasive)

---

OSPE: Congenital Erythropoietic Porphyria (CEP) (7 marks)

Q1. Likely diagnosis? (1 mark)

Q2. Mode of inheritance? (1 mark)

Q3. Biosynthetic pathway affected & enzyme defect? (2 marks)

• Pathway affected: Haem biosynthesis pathway (Porphyrin synthesis)
• Enzyme defect: Uroporphyrinogen III cosynthase (also called Uroporphyrinogen III synthase) deficiency
• Normally: Hydroxymethylbilane is converted to Uroporphyrinogen III (correct isomer) by this enzyme
• In CEP: Without this enzyme, Hydroxymethylbilane spontaneously cyclizes to Uroporphyrinogen I (abnormal isomer) which cannot be converted to haem and accumulates
• Excess Uroporphyrinogen I is oxidized to Uroporphyrin I and Coproporphyrin I - these accumulate in tissues, RBCs, and urine

Q4. Urinary finding? (1 mark)

Q5. Why does the patient show photosensitivity? (1 mark)

• Accumulated porphyrins (Uroporphyrin I) are photosensitizers
• On absorbing UV/visible light (~400-410 nm, Soret band), porphyrins become excited and react with oxygen to produce reactive oxygen species (ROS) / free radicals
• These free radicals damage cell membranes, leading to blistering, tissue destruction, and inflammation of skin
• Repeated photodamage causes scarring, hypertrichosis (excess hair - erythropoietin stimulation), and mutilation

Q6. Treatment plan? (1 mark)

• Strict sun avoidance - protective clothing, broad-spectrum sunscreen, tinted windows
• Activated charcoal or cholestyramine - to bind porphyrins in gut and reduce absorption
• Blood transfusions - to suppress erythropoiesis and reduce porphyrin production
• Hydroxycarbamide (hydroxyurea) - suppresses erythropoiesis
• Splenectomy if haemolytic anaemia is severe
• Bone marrow/stem cell transplantation - only curative treatment

---

OSPE: Folate Deficiency / Megaloblastic Anaemia (8 marks)

Q1. Probable deficiency? (1 mark)

• FIGLU accumulates because its catabolism requires folate (as tetrahydrofolate/THF to accept formimino group). High urinary FIGLU = FIGLU test = marker of folate deficiency.

Q2. Treatment plan? (1 mark)

• Folic acid supplementation: 5 mg/day orally (therapeutic dose for established deficiency); prophylactic dose in pregnancy is 400-800 mcg/day
• In pregnancy: start before conception and continue through at least 1st trimester to prevent neural tube defects
• Treat underlying cause (dietary improvement, treat malabsorption)

Q3. Causes of folate deficiency (2 marks)

1. Inadequate intake: Poor diet (alcoholics, poverty, elderly, exclusively milk-fed infants); Folate is destroyed by prolonged cooking
2. Increased demand: Pregnancy (most common reason in this case - fetal demands), lactation, haemolytic anaemias, rapid cell division
3. Malabsorption: Coeliac disease, Crohn's disease, tropical sprue
4. Drug-induced: Methotrexate (folate antagonist), Trimethoprim, Phenytoin (impairs absorption), Oral contraceptives
5. Alcoholism: Poor diet + impairs folate absorption and utilization

Q4. Rich dietary sources of Folate (2 marks)

• Best sources: Liver, kidney, green leafy vegetables (spinach, asparagus, broccoli, lettuce), legumes (lentils, chickpeas), yeast extract, fortified cereals
• Note: "Folate" comes from "folium" (leaf) - hence abundant in green leafy foods
• Lightly cooked or raw vegetables preserve folate better (heat-labile)

Q5. Method of estimation? (1 mark)

1. Serum folate (reflects recent intake)
2. Red cell folate (reflects tissue stores - more reliable indicator of long-term status)
3. FIGLU excretion test (Histidine loading test): Oral histidine load → measure urinary FIGLU; elevated FIGLU indicates folate deficiency
4. Microbiological assay using Lactobacillus casei

Q6. Reason for abnormal blood picture (megaloblastic anaemia)? (2 marks)

• Folate (as THF/Tetrahydrofolate) is essential for one-carbon transfer reactions
• Most critically, folate is needed for synthesis of thymidylate (dTMP) from dUMP via thymidylate synthase (requires 5,10-methylene THF)
• Without adequate thymidine, DNA synthesis is impaired but RNA and protein synthesis continue normally
• This leads to nuclear-cytoplasmic asynchrony: nucleus cannot divide but cytoplasm continues to grow → megaloblasts (large, abnormal immature RBCs with large nuclei and open chromatin pattern)
• These large, fragile cells are destroyed in marrow (ineffective erythropoiesis) → anaemia
• Mature RBCs in blood are large (macrocytosis) with hypersegmented neutrophils (>5 lobes)

---

OSPE: Xeroderma Pigmentosum (XP) (8 marks)

Q1. Probable diagnosis? (1 mark)

Q2. Genetic defect? (1 mark)

• Most commonly mutations in XPC or XPA genes
• These genes encode proteins that recognize and repair UV-induced DNA damage (pyrimidine dimers)

Q3. Mechanism of skin blister formation on sun exposure? (2 marks)

• UV radiation (especially UV-B, 290-320 nm) causes formation of pyrimidine dimers (mainly cyclobutane pyrimidine dimers - CPDs and 6-4 photoproducts) in DNA
• Normally, Nucleotide Excision Repair (NER) recognizes and removes these lesions (damage recognition → incision → excision of ~30-nucleotide patch → resynthesis using complementary strand → ligation)
• In XP: NER is defective due to mutant XP proteins
• UV-damaged DNA cannot be repaired → DNA replication errors → mutations in tumor suppressor genes and proto-oncogenes → apoptosis of damaged cells → blistering, skin inflammation
• Repeated UV damage with defective repair leads to rapid accumulation of mutations → skin cancers (1000x increased risk)

Q4. Other types of DNA repair mechanism defects (2 marks)

1. Base Excision Repair (BER) defects: Removes small base lesions (oxidized, alkylated, deaminated bases). Example: MUTYH-associated polyposis
2. Mismatch Repair (MMR) defects: Repairs replication errors (mismatched base pairs, insertion-deletion loops). Lynch syndrome (HNPCC) - MLH1, MSH2 mutations
3. Homologous Recombination (HR) defects: Repairs double-strand breaks. BRCA1/BRCA2 mutations → breast and ovarian cancer
4. Non-Homologous End Joining (NHEJ) defects: Another DSB repair pathway; Severe combined immunodeficiency (SCID)
5. Translesion Synthesis (TLS) defect: XP-variant (XPV) - mutation in DNA polymerase eta (pol η), which normally bypasses CPDs accurately

Q5. Pattern of inheritance? (1 mark)

Q6. Investigations to confirm diagnosis? (1 mark)

1. UV irradiation assay of cultured skin fibroblasts - measure unscheduled DNA synthesis (UDS) after UV exposure; absent/reduced in XP
2. Molecular genetic testing (DNA sequencing) for mutations in XP genes
3. Skin biopsy with histology and immunohistochemistry
4. Complementation group analysis - to classify which XP gene is mutated

---

OSPE: Acute Intermittent Porphyria (AIP) (Valproic acid/epilepsy case)

Q1. Likely diagnosis & mode of inheritance?

Q2. Biosynthetic pathway affected & enzyme defect?

• Pathway: Haem biosynthesis pathway
• Enzyme defect: Porphobilinogen deaminase (also called Hydroxymethylbilane synthase / Uroporphyrinogen I synthase) - 50% reduction in activity
• Due to this: ALA (delta-aminolevulinic acid) and porphobilinogen (PBG) accumulate in blood and urine

Q3. Urine colorless when voided but darkens on exposure to air/light - why?

• Initially colorless porphobilinogen (PBG) is excreted in urine
• On exposure to air and light, PBG spontaneously polymerizes and oxidizes to form porphobilin (dark brown) and uroporphyrin (red/dark colored)
• Hence, fresh urine is colorless but darkens on standing ("port wine" colored)

Q4. Why valproic acid acts as precipitating factor?

• Valproic acid (and many other drugs - barbiturates, sulfonamides, OCP, rifampicin) are metabolized by the liver and induce cytochrome P450 enzymes
• Cytochrome P450 enzymes are haem-containing enzymes; increased demand for haem requires upregulation of ALA synthase (ALAS1) - the rate-limiting first enzyme of haem synthesis
• In AIP patients with partial enzyme block, increased ALA synthase activity leads to massive overproduction and accumulation of ALA and PBG in the pathway above the block
• This precipitates acute attacks
• Other precipitants: Fasting/starvation (as in this case - no food for 2 days), alcohol, infections, hormonal changes (progesterone - attacks common premenstrually), stress

---

OSPE: Biotin Deficiency (Raw Eggs)

a) Vitamin deficiency:

b) Other causes of deficiency:

1. Avidin in raw egg white (main cause here - avidin is a glycoprotein that binds biotin with very high affinity, preventing its absorption; cooking denatures avidin)
2. Prolonged parenteral nutrition without biotin supplementation
3. Biotinidase deficiency (genetic - cannot recycle biotin from biocytin)
4. Holocarboxylase synthase deficiency (genetic)
5. Antibiotic use - destroys intestinal bacteria that synthesize biotin
6. Alcoholism and inflammatory bowel disease (malabsorption)

c) Sources:

d) Coenzyme roles of Biotin (carboxylation reactions):

1. Pyruvate Carboxylase: Pyruvate → Oxaloacetate (gluconeogenesis from pyruvate)
2. Acetyl-CoA Carboxylase: Acetyl-CoA → Malonyl-CoA (first committed step of fatty acid synthesis)
3. Propionyl-CoA Carboxylase: Propionyl-CoA → Methylmalonyl-CoA (odd-chain FA, valine, isoleucine catabolism)
4. Beta-Methylcrotonyl-CoA Carboxylase: Leucine catabolism

e) How raw eggs cause deficiency & how to avoid:

• Raw egg white contains Avidin (a glycoprotein/antinutrient) that binds biotin with extraordinary affinity (Kd ~10^-15 M)
• Avidin-biotin complex is not absorbed in the intestine → biotin deficiency despite adequate intake
• Prevention: Cook eggs thoroughly - cooking at high temperature denatures avidin, destroying its ability to bind biotin; cooked egg yolk is actually a good source of biotin

f) Daily requirement (RDA):

• 30 mcg/day for adults
• No official RDA set in India; Adequate Intake (AI) = 30 mcg/day

g) Use in laboratory practice:

• Biotin-avidin/streptavidin system - widely used as a detection system in immunoassays (ELISA, Western blot, immunohistochemistry, FISH) due to extremely high-affinity binding
• Biotin-labeled probes/antibodies + streptavidin-enzyme conjugate for signal amplification

h) Chemistry of Biotin:

• Biotin is a bicyclic compound consisting of a ureido ring fused with a tetrahydrothiophene ring with a valeric acid side chain
• Water-soluble vitamin; stable to heat in cooking (except extreme conditions)
• Active form is biocytin (biotin covalently linked to lysine residue of apoenzyme via amide bond)
• Molecular formula: C10H16N2O3S; Molecular weight: 244 Da

i) Methods of estimation:

1. Microbiological assay (Lactobacillus plantarum)
2. Avidin-binding assay (biotin binds radioactive/fluorescent avidin)
3. HPLC (High Performance Liquid Chromatography)

---

OSPE: Riboflavin (Vitamin B2) Deficiency

a) Probable deficiency:

b) Investigations:

1. Erythrocyte Glutathione Reductase Activation Coefficient (EGR-AC): Best functional test. Measures activity of RBC glutathione reductase (FAD-dependent) ± FAD stimulation. Activity coefficient >1.2 = deficiency.
2. Urinary riboflavin excretion (below 30 mcg/day = deficiency)
3. Serum/plasma riboflavin levels (HPLC)
4. Microbiological assay (Lactobacillus casei)

c) Treatment plan:

• Oral Riboflavin 5-10 mg/day until clinical improvement, then dietary modification
• Multivitamin B complex supplementation (B-vitamin deficiencies often coexist)
• Dietary counselling: include milk, eggs, meat, fish, leafy vegetables

d) Causes of deficiency:

1. Inadequate dietary intake - poor diet, fussy eaters (as in this child)
2. Malabsorption - gastrointestinal disorders
3. Photodegradation - milk stored in clear glass bottles loses riboflavin when exposed to sunlight
4. Alcoholism - poor diet + impaired absorption
5. Increased demand - pregnancy, lactation, febrile illness, hypothyroidism (thyroxine stimulates riboflavin conversion to FAD/FMN)
6. Drugs - probenecid, chlorpromazine (impair conversion to coenzyme forms)

e) Prevention:

• Diverse diet including dairy, eggs, meat, green vegetables
• Fortification of flour and cereals with riboflavin
• Store milk in opaque containers (protect from light)
• Avoid over-cooking vegetables

f) Chemistry of Riboflavin:

• Riboflavin = isoalloxazine ring (tricyclic) attached to ribitol (5-carbon sugar alcohol) side chain
• Yellow-colored, water-soluble vitamin
• Fluorescent (yellow-green fluorescence in solution)
• Heat stable, but sensitive to alkali and UV light/visible light
• Active coenzyme forms: FMN (Flavin Mononucleotide) and FAD (Flavin Adenine Dinucleotide)
• FMN = Riboflavin + phosphate; FAD = FMN + AMP

g) Sources and RDA:

• Sources: Milk and milk products (best source), organ meats (liver, kidney), eggs, fish, poultry, yeast, green leafy vegetables (spinach, broccoli), whole grains, mushrooms
• RDA: 1.2-1.7 mg/day for adults; slightly more in pregnancy (1.4 mg) and lactation (1.6 mg)

h) Method of estimation:

1. Fluorometry - riboflavin is naturally fluorescent (excitation 450 nm, emission 520 nm); most common method
2. HPLC - gold standard, most accurate
3. Microbiological assay (Lactobacillus casei)

---

OSPE: Niacin (Pellagra) Deficiency

a) Probable deficiency:

• Classic "3 Ds": Dermatitis (symmetric, sun-exposed areas, "Casal's necklace"), Diarrhea, Dementia (memory impairment, depression)
• 4th D = Death if untreated
• Corn diet: maize has niacin in bound form (niacytin) that is not bioavailable; also lacks tryptophan (precursor to niacin synthesis)
• Alcohol: poor diet + impairs absorption

b) Investigations:

1. Urinary excretion of N1-methylnicotinamide (major metabolite) - decreased in deficiency; ratio of N1-methylnicotinamide to 2-pyridone
2. Plasma niacin/nicotinamide levels (HPLC)
3. Red cell NAD levels (functional marker)

c) Treatment plan:

• Nicotinamide (niacinamide) 50-500 mg/day in divided doses (preferred over nicotinic acid - no flushing side effect)
• Or Nicotinic acid 100-300 mg/day
• B-complex vitamins (other deficiencies often coexist)
• Treat underlying alcoholism; improve diet

d) Causes of deficiency:

1. Inadequate intake - corn/maize-based diets (tryptophan-poor, niacin in bound unavailable form)
2. Alcoholism (poor diet, impaired absorption)
3. Carcinoid syndrome - tryptophan diverted to serotonin instead of niacin synthesis
4. Hartnup disease - genetic disorder of neutral amino acid transport; tryptophan absorption is impaired → pellagra-like features
5. Isoniazid (INH) therapy for TB - INH is a pyridoxine antagonist; pyridoxal phosphate (PLP) is needed for tryptophan → niacin conversion; INH depletes PLP → impairs niacin synthesis
6. Liver disease - impaired niacin metabolism

e) Prevention:

• Treat corn with alkali (nixtamalization - traditional Mexican process) - liberates bound niacin
• Diversified diet including meat, fish, groundnuts
• Food fortification

f) Chemistry of Niacin:

• Niacin = pyridine-3-carboxylic acid (nicotinic acid) or its amide (nicotinamide)
• Water-soluble, heat stable, stable to acid and alkali
• Active coenzyme forms: NAD+ (Nicotinamide Adenine Dinucleotide) and NADP+ (NAD Phosphate)
• NAD+/NADH participates in electron transport chain, glycolysis, TCA cycle, beta-oxidation (catabolism)
• NADP+/NADPH participates in anabolic reactions (fatty acid synthesis, cholesterol synthesis, HMP pathway, antioxidant defense via glutathione reductase)
• Niacin can also be synthesized from tryptophan (60 mg tryptophan → 1 mg niacin; requires pyridoxal phosphate)

g) Sources, RDA, and method of estimation:

• Sources: Meat (beef, chicken, liver), fish (tuna, salmon), peanuts, yeast, cereals, mushrooms, coffee
• RDA: 14-18 mg Niacin Equivalents (NE)/day (1 NE = 1 mg niacin or 60 mg dietary tryptophan)
• Method of estimation:
  1. Colorimetric (König reaction): Niacin reacts with cyanogen bromide and aromatic amine to give colored product
  2. Fluorometric assay of urinary metabolites
  3. HPLC
  4. Microbiological assay (Leuconostoc mesenteroides)

---

OSPE: Pyridoxine (Vitamin B6) Deficiency

a) Probable deficiency:

• INH (Isoniazid) is a structural analog of pyridoxine and competes with and inactivates pyridoxal phosphate (PLP) → functional B6 deficiency
• Also: alcoholism impairs B6 metabolism; maize diet is poor in tryptophan (needs B6 for conversion to niacin → pellagra-like features)

b) Investigations:

1. Plasma Pyridoxal Phosphate (PLP) level - direct measure; most reliable
2. Erythrocyte AST (EAST) activation coefficient - PLP-dependent enzyme; activity stimulated by added PLP; ratio >1.5 = deficiency
3. Urinary xanthurenic acid after tryptophan loading test (tryptophan → kynurenine → xanthurenic acid: elevated in B6 deficiency as kynureninase is PLP-dependent)
4. Urinary 4-pyridoxic acid (major metabolite) - decreased

c) Treatment plan:

• Pyridoxine (Vit B6) 10-50 mg/day (prophylaxis with INH therapy: 10-25 mg/day)
• In frank deficiency: 50-100 mg/day
• All patients on INH should receive prophylactic pyridoxine (especially alcoholics, malnourished, diabetics, pregnant women)
• Address alcoholism and improve dietary intake

d) Causes of deficiency:

1. Drugs: INH (most important), oral contraceptives, penicillamine, cycloserine (another antitubercular), hydralazine, L-DOPA (all are B6 antagonists)
2. Alcoholism - acetaldehyde (alcohol metabolite) inactivates PLP; poor diet
3. Dependency syndromes (pyridoxine-dependent seizures in neonates)
4. Malabsorption - IBD, celiac disease
5. Pregnancy - increased demand

e) Prevention:

• Routine prophylactic pyridoxine supplementation with all INH-containing ATT regimens
• Moderate alcohol consumption; nutritious diet

f) Chemistry of Vitamin B6:

• Three natural forms: Pyridoxol (pyridoxine), Pyridoxal, Pyridoxamine - all are 2-methyl-3-hydroxy-5-hydroxymethyl pyridine derivatives
• Active coenzyme form: Pyridoxal Phosphate (PLP) - phosphorylated form of pyridoxal
• Water-soluble; heat stable in acid, labile in alkali and UV light
• Molecular formula: C8H11NO3 (pyridoxine)

g) Sources, RDA, and method of estimation:

• Sources: Meat, poultry, fish (tuna, salmon), potatoes, bananas, fortified cereals, nuts, legumes, yeast
• RDA: 1.3-2.0 mg/day adults; higher in pregnancy (1.9 mg) and lactation (2.0 mg)
• Methods of estimation:
  1. Microbiological assay (Saccharomyces cerevisiae or Lactobacillus casei)
  2. Fluorometric assay for plasma PLP
  3. HPLC (gold standard)
  4. Enzymatic assays (EAST/EGOT activation coefficient)

---

OSPE: Vitamin B12 Deficiency (Strict Vegan)

a) Probable deficiency:

• Key differentiator from folate deficiency: elevated urinary methylmalonic acid (MMA) - because methylmalonyl-CoA mutase requires B12 (as adenosylcobalamin); in B12 deficiency, methylmalonyl-CoA cannot be converted to succinyl-CoA → MMA accumulates
• Neurological symptoms (subacute combined degeneration of spinal cord - loss of sensation, mental confusion) also point to B12 deficiency (folate does NOT cause neurological symptoms)

b) Investigations:

1. Serum Vitamin B12 (cobalamin) level (low <200 pg/mL)
2. Serum/urine Methylmalonic Acid (MMA) - elevated (specific to B12 deficiency, not folate)
3. Serum homocysteine - elevated (elevated in both B12 and folate deficiency)
4. Complete blood count + peripheral smear: macrocytosis, hypersegmented neutrophils, pancytopenia
5. Serum folate and red cell folate (to distinguish from folate deficiency; both elevated MMA and neurological features point to B12)
6. Anti-intrinsic factor antibodies (if pernicious anemia suspected)
7. Schilling test (to determine cause of B12 deficiency - dietary vs. malabsorption)

c) Treatment plan:

• Hydroxocobalamin (or cyanocobalamin): 1000 mcg IM daily for 1 week, then weekly for 4 weeks, then monthly for life (if pernicious anemia or permanent malabsorption)
• Oral B12 1000-2000 mcg/day (effective even without intrinsic factor via passive absorption at high doses - adequate for dietary deficiency in vegans)
• Dietary modification: Vegans should take B12-fortified foods (fortified cereals, plant milks) or supplements
• Treat underlying cause

d) Causes of deficiency:

1. Dietary deficiency: Strict veganism (B12 is found ONLY in animal products: meat, fish, eggs, dairy)
2. Pernicious Anaemia (most common cause in developed countries): Autoimmune destruction of gastric parietal cells → deficiency of intrinsic factor (IF) → B12 cannot be absorbed in terminal ileum
3. Gastrectomy or gastric bypass surgery (loss of IF-secreting parietal cells)
4. Terminal ileum disease/resection (Crohn's disease, tropical sprue) - site of B12 absorption
5. Bacterial overgrowth (small intestine) - bacteria consume B12
6. Fish tapeworm (Diphyllobothrium latum) - competes for B12
7. Drugs: Metformin (impairs B12 absorption), PPI/antacids, N2O anesthesia (oxidizes B12)
8. Transcobalamin II deficiency (rare genetic transport defect)

e) Prevention:

• Vegans/vegetarians must supplement B12 or consume fortified foods
• Regular monitoring of B12 levels in high-risk groups (vegans, elderly, those on metformin)
• B12 fortification of plant-based foods

f) Chemistry of Vitamin B12:

• Most complex vitamin - largest vitamin molecule
• Corrin ring structure with a cobalt atom at the center (organometallic compound)
• Only vitamin synthesized exclusively by microorganisms (bacteria, fungi); not synthesized by animals or plants
• Coenzyme forms:
  1. Methylcobalamin (methyl-B12): Required for methionine synthase (homocysteine + methyl-THF → methionine + THF); links B12 and folate metabolism
  2. Adenosylcobalamin (5'-deoxyadenosylcobalamin / coenzyme B12): Required for methylmalonyl-CoA mutase (methylmalonyl-CoA → succinyl-CoA; propionate metabolism)
• Cyanocobalamin - synthetic pharmacological form (stable, converted to active forms in body)
• Absorption requires intrinsic factor (IF) secreted by gastric parietal cells; IF-B12 complex absorbed in terminal ileum via cubilin receptors
• R-protein (haptocorrin) carries B12 in stomach and blood

g) Sources and RDA:

• Sources: Exclusively animal products - Liver (richest source), meat, fish (sardines, tuna), shellfish, eggs, dairy (milk, cheese). Fermented foods may have small amounts. No plant sources (algae is debated/unreliable)
• RDA: 2.4 mcg/day adults; 2.6 mcg/day pregnancy; 2.8 mcg/day lactation

h) Method of estimation:

1. Microbiological assay (Lactobacillus leichmannii) - historical
2. Competitive protein binding radioimmunoassay (RIA) - widely used
3. Immunoassay (ELISA, chemiluminescent)
4. HPLC with mass spectrometry (LC-MS/MS) - most accurate

---

OSPE: Pantothenic Acid (Vitamin B5) Deficiency - Burning Feet Syndrome

a) Deficient vitamin:

• "Burning Feet Syndrome" (nutritional melalgia/Gopalan's syndrome) is classically associated with pantothenic acid deficiency

b) Chemistry and functions:

• Pantothenic acid = beta-alanine linked to pantoic acid via amide bond
• Water-soluble, yellow oil/sodium salt (white crystals)
• Heat labile, sensitive to acid and alkali
• Widely distributed in nature - name from Greek "pantothen" = "from everywhere"
• Active form: Component of Coenzyme A (CoA-SH) and Acyl Carrier Protein (ACP)
• CoA structure: Pantothenic acid + beta-mercaptoethylamine + adenosine-3'-phosphate-5'-pyrophosphate

1. Acyl group transfer - CoA-SH is a universal carrier of acyl groups (e.g., Acetyl-CoA, Succinyl-CoA, Propionyl-CoA)
2. Carbohydrate metabolism: Acetyl-CoA enters TCA cycle; Pyruvate dehydrogenase complex needs CoA
3. Fatty acid oxidation: Fatty acyl-CoA is the activated form of fatty acids for beta-oxidation
4. Fatty acid synthesis: ACP carries the growing acyl chain in fatty acid synthase (FAS) complex
5. Ketone body synthesis: HMG-CoA synthesis and ketogenesis requires Acetyl-CoA (CoA)
6. Cholesterol and steroid synthesis: HMG-CoA reductase pathway starts with Acetyl-CoA
7. Amino acid catabolism: Several amino acids enter TCA cycle via CoA derivatives
8. Acetylation reactions: Acetyl-CoA donates acetyl group for acetylation of proteins, histones (epigenetics), drugs (e.g., sulfonamide metabolism)
9. Sphingolipid synthesis (requires CoA)

c) Dietary sources and RDA:

• Sources: Found in almost all foods ("pantothen" = everywhere) - Liver, kidney, egg yolk, meat, fish, whole grains, legumes, mushrooms, avocado, broccoli, sweet potatoes, royal jelly
• RDA: 5 mg/day for adults (Adequate Intake); 6 mg/day in pregnancy; 7 mg/day in lactation
• Deficiency is rare because pantothenic acid is ubiquitous; occurs mainly in severe malnutrition, war famine, or experimental deprivation

d) Why coenzyme A is called the "Molecule of Metabolic Integration"?

• Coenzyme A (CoA-SH) - the active coenzyme form of pantothenic acid - is called the "molecule of metabolic integration" because:
• It serves as the common currency connecting multiple major metabolic pathways
• Acetyl-CoA (the acetylated form) is the point of convergence of:
  • Carbohydrate metabolism (glycolysis → pyruvate → Acetyl-CoA via PDH complex)
  • Fatty acid oxidation (beta-oxidation produces Acetyl-CoA)
  • Amino acid catabolism (several amino acids → Acetyl-CoA or other CoA derivatives)
• And Acetyl-CoA then feeds into:
  • TCA cycle (energy production)
  • Fatty acid synthesis (lipogenesis)
  • Ketone body synthesis (ketogenesis)
  • Cholesterol/steroid synthesis
  • Acetylcholine synthesis
  • Acetylation of proteins/drugs
• Thus, CoA integrates catabolism and anabolism across carbohydrates, fats, and proteins - making it the central molecule of metabolic integration in the body.

---